HomeFile

File

View Category
Coronary disease

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Impact of Tricuspid Regurgitation in Mitral V-in-V

The coexistence of mitral regurgitation (MR) and tricuspid regurgitation (TR) presents a therapeutic dilemma. While surgery is...
Dr. Carlos Fava -
Learn More
Other

Long-Term Outcomes of PFO Closure

Patent foramen ovale (PFO) is a recognized cause of cryptogenic stroke, and its closure via percutaneous treatment...
Dr. Carlos Fava -
Learn More
Structural heart disease

Post-TAVR Pacemaker Implantation in Aortic Regurgitation

Transcatheter aortic valve replacement (TAVR) has emerged as a therapeutic alternative to treat aortic regurgitation, especially in...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

Early Discharge After STEMI: Clinical Benefit and Cost-Effectiveness?

Improvements in reperfusion strategies for ST-segment elevation myocardial infarction (STEMI) have transformed the prognosis for this condition....
Dr. Omar Tupayachi -
Learn More
Chronic Ischemic cardiopathy

Can Intense Exercise Modify the Coronary Atherosclerosis Profile?

While physical activity is a widely accepted recommendation for preventing cardiovascular disease, questions remain regarding the impact...
Dr. Juan Manuel Pérez -
Learn More
Structural heart disease

Heterotopic Treatment of the Tricuspid Valve

Tricuspid regurgitation (TR) has been associated to high morbimortality, mainly due to the development of cardiac failure,...
Dr. Carlos Fava -
Learn More
Chronic Coronary Syndromes

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which...
Dr. Omar Tupayachi -
Learn More